SAM #75N98026Q01133

NIH Solicitation for NULISAseq Inflammation Panel Service for Biomarker Profiling

This opportunity is issued by the National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, for a specialized inflammation panel service. - Government Buyer: - National Institutes of Health (NIH), Office of the Director, Office of Acquisitions - OEMs and Vendors: - No specific OEMs or vendors are named, but the service is referred to as 'NULISAseq Inflammation panel service.' - Products/Services Requested: - Inflammation Panel service to profile 250+ biomarkers of inflammation and immune response in cerebral organoid samples - Measures over 250 proteins from as little as 10ul of sample - High sensitivity (fg/ml levels), wide dynamic range (12 logs), and reproducibility (<10% intra- and inter-plate CV) - One package of service (2 plates) - Delivery to Bethesda, MD within 30 days after order receipt - Unique/Notable Requirements: - Service must deliver high sensitivity and reproducibility for small sample volumes - Non-competitive, firm-fixed price procurement - Delivery required within 30 days - Service is intended for advanced biomarker profiling in cerebral organoid research - Period of Performance: - One year duration - Service to be performed between September 15, 2026, and September 14, 2027

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.(ii) The solicitation number is 75N98026Q01133 and the solicitation is issued as a Notice of Intent (NOI) of a non-competitive (notice of intent) combined synopsis solicitation to award a contract or purchase order without providing for full or open competition (including brand-name).This acquisition is conducted under the authority of the FAR Part 12.603¿ Streamlined solicitation for commercial products or commercial services, and is not expected to exceed the simplified acquisition threshold, and the authority of 41 U.S.C. 1901 and the statutory authority of FAR 6.302-3(a)(2)(ii).

View original listing